Liang Yao

机构：Hohai University, Nanyang Technological University, Northeast Electric Power University, Shanxi Provincial Cancer Hospital, Jiangxi Maternal and Child Health Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, McMaster University · ORCID：0000-0003-4068-3136

发表论文 376 篇 · 总被引 7510 次 · h-index 47

代表论文

• Estimating minimal, moderate, and marked clinically important differences for patient reported outcome measure in randomised controlled trial (2026 · Chinese Medical Journal · 被引 6)
• Exploring chamazulene as a novel therapeutic agent for breast cancer in silico and in vitro: apoptosis induction, cell cycle regulation, and antimetastatic effects (2025 · Frontiers in Pharmacology · 被引 2)
• KCTD15 Enhances Stem Cell‐Like Properties and Promotes Triple‐Negative Breast Cancer Progression Through KLF4 /β‐Catenin Signaling (2026 · The FASEB Journal · 被引 1)
• Targeting neuroinflammation and PVNCRH neurons: dexmedetomidine liposomes for perioperative neurocognitive disorder with comorbid anxiety (2025 · Materials Today Bio · 被引 1)
• Complexities in the Terminology Used for Describing, Diagnosing, and Classifying Retinal Vasculitis: A Scoping Review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe)–Report 6 (2025 · Ocular Immunology and Inflammation · 被引 1)
• Covert mortality nodavirus identified as a new causative agent in bivalves (2025 · Aquaculture · 被引 1)